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The NF-kB family of transcription factors are key mediators of the immune and 
inflammatory response to a diverse range of environmental and microbiological 
exposures. However the role of NF-kB extends beyond transcriptional control of the 
immune response and it is also involved in maintaining the structure and function of 
many tissues. To serve such a multitude of functions NF-kB has developed the 
capacity to generate transcriptional responses that are both stimulus-specific and cell 
specific. Because of this NF-kB signalling has become a paradigm in cell signalling 
research.   
 
There are 5 proteins within the NF-kB group, which normally exist as homo- and 
heterodimers. The dimers are complexed with a member of the IkB family which is 
responsible for maintaining the cytoplasmic localization of NF-kB.  When cells are 
activated IkB is phosphorylated, dissociates from the NF-kB complex and is 
degraded. NF-kB then migrates to the nucleus where it  binds to kB consensus 
sequences, controlling the expression of over 100 genes,1  including many of the 
genes involved in the immune response. This traditional view of NF-kB biology is an 
over-simplification  as in fact this is a very dynamic system with constant shuttling of 
NF-kB between the cytoplasm and the nucleus with, in the presence of IkB proteins, 
the equilibrium lying towards cytoplasmic localization. 
 
Because of its many effects it is perhaps not surprising that the activation of NF-kB 
has been implicated in many pathological conditions. Tight control of NF-kB 
activation is critical in preventing tisuue injury. In any circumstance in which 
excessive or inappropriate activation of the immune system occurs and tissue injury 
ensues NF-kB is probably involved. Inherited variability in control of NF-kB 
activation has been proposed as the cause of some autoinflammatory diseases2 
suggesting that activation of NF-kB alone, in the absence of another stimuli, can be 
harmful. In inflammatory renal disease excess activation of NF-kB can be 
demonstrated3 and in animal models inhibition of NK-kB tends to limit injury.4, 5 The 
situation may be even more complex as in addition to causing injury NF-kB, 
particularly the p50 protein, may also limit inflammation and play a key role in 
resolution of inflammation and tissue remodelling.6, 7 
 
In this edition of the JASN Hussain and colleagues describe the glomerular pathology 
that develops in mice with a genetically engineered defect in the control of NF-kB 
activation.8  Spontaneous glomerular disease occurs within the first two weeks of life 
with clear evidence of podocyte injury associated with nuclear translocation of NF-
kB. It is not known which of the many potential NF-kB inducible genes are 
responsible for podocyte injury. However, there is little doubt that NF-kB activation 
can cause glomerular injury and any stimulus that activates NF-kB could disrupt 
podocyte function. This would leave the podocyte very sensitive to any perturbation 
in its external environment and such a powerful system as NF-kB needs to be 
controlled. The podocyte protein nephrin may be part of this control system. 
 
Nephrin is a transmembrane protein and a member of the immunoglobulin 
superfamily. It is a vital component of the podocyte slit diaphragm which is involved 
in maintaining the glomerular filtration barrier. Mutations in the nephrin gene lead to 
congenital nephrotic syndrome of the Finnish type, characterized by heavy 
proteinuria. Also reduced nephrin expression is seen in other proteinuric glomerular 
diseases. The extracellular domains of nephrin interact with other nephrin molecules 
on adjacent foot processes, maintaining the structure of the slit diaphragm. There are 
other proteins present at the junction between adjacent foot processes, forming a 
protein complex similar to tight and adherens junctions. Within this complex nephrin 
serves an important signalling function, linking extracellular structures within the slit 
diaphragm to the actin cytoskeleton.9 This is achieved by its intracellular domain 
which contains nine tyrosine residues and is able to interact with several adaptor 
signalling proteins.  
 
Hussain et al8 suggest an additional role for nephrin, as a brake on NF-kB signalling. 
Human podocytes that express mutant nephrin demonstrate increased activation of 
NF-kB and this is reversed by restoration of wild type nephrin expression. The link 
between nephrin and NF-kB is likely to be complex, but the authors propose one 
possible link. Nephrin can bind atypical Protein Kinase C (aPKC), an enzyme that 
acts as an activator of the NF-kB pathway. For some reason the distribution of aPKC 
is different in podocytes that express wild type and mutant nephrin. With mutant 
nephrin aPKC shows cytoplasmic localization where it can activate pathways leading 
to IkB degradation. In addition, a dominant negative form of aPKC blocks nephrin 
induced suppression of NF-kB activity. These in vitro observations are also consistent 
with the mouse data. The excessive activation of NF-kB in the mouse model 
described is due to a deficiency in prostate apoptosis response 4 (Par4). One function 
of Par4 is to bind and inhibit aPKC and it is therefore a negative regulator of NF-kB. 
However, as the author point out, this may not be the only way in which nephrin and 
NF-kB interact. 
 
This work raises some interesting questions. Firstly, why should nephrin have 
developed a mechanism to interact with NF-kB signalling pathways? If the model 
proposed by Hussain et al is correct then a stimulus that disrupts the structure of the 
slit diaphragm will interfere with nephrin function and thereby increase NF-kB 
activation. This would ultimately lead to a further deterioration in glomerular 
filtration function and finally overt glomerular disease. An alternative explanation is 
that the podocyte is utilising nephrin to sense perturbations in the extracellular space 
leading to NF-kB-mediated responses that are protective. This leads to second 
question, namely does NF-kB have a physiologically important role in the 
maintenance of podocyte structure and function and if so what is this role? A final 
possibility is that nephrin represents the physiological off switch for NF-kB signalling 
in the podocyte. When the normal structure of the slit diaphragm and nephrin 
functions are restored nephrin would inhibit aPKC activity. This would reduce IkB 
phosphorylation and degradation, therefore restoring the cytoplasmic localization of 
inactive NF-kB. 
 
The more nephrology learns about podocyte function the more the divide between 
proteins of the immune system and epithelial cells narrows. The paper by Hussain et 
al describes the archetypal transcription factor of the immune system causing injury in 
an epithelial cell and controlled by a mechanism that is unique to a specific cell type 
within the glomerulus. This follows recent observations that Cyclosporin may reduce 
proteinuria, not by influencing T cell function but, by inhibiting calcineurin-
dependent dephosphorylation of synaptopodin.10  Synaptopodin is another protein 
found within junctional complexes in podocytes and has an important role in 
stabilizing the actin cytoskeleton. These two studies not only provide fascinating 
insights into podocyte function but alter the way we look at proteinuric disease and its 
treatment. 
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